Opioids
The AHA, American Society of Health-System Pharmacists, American Society of Anesthesiologists, Institute for Safe Medication Practices, and American Society of Clinical Oncology today urged the Drug Enforcement Administration to temporarily adjust the aggregate production quotas for certain…
The undersigned groups respectfully request that the Drug Enforcement Administration (DEA)
adjust aggregate production quotas (APQ) for certain opioids in order to mitigate ongoing drug
shortages.
U.S. deaths from alcohol, drugs and suicide increased by 11% in 2016, to nearly 142,000, according to a report released today by Trust for America’s Health and Well Being Trust.
The Centers for Disease Control and Prevention and Food and Drug Administration are investigating a multistate outbreak of salmonella linked to products reported to contain kratom.
Responding to a request from Senate Finance Committee leaders for policy recommendations to address the opioid epidemic, AHA urged the committee Friday to preserve health insurance coverage through the exchanges and Medicaid.
The American Hospital Association responds to the Senate Finance Committee’s request for policy recommendations to address the opioid epidemic.
The Substance Abuse and Mental Health Services Administration yesterday issued guidance for health care and addiction professionals using methadone, naltrexone or buprenorphine to treat patients with opioid use disorder.
The House Ways and Means Committee today held a hearing on the Department of Health and Human Services’ fiscal year 2019 budget request, at which HHS Secretary Alex Azar testified.
The Substance Abuse and Mental Health Services Administration today issued new clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants.
Panelists discussed proactive, preventative approaches to care aid in population health strategies, and a case study in targeting opioid substance use disorder in communities.